Supramolecular filaments for concurrent ACE2 docking and enzymatic activity silencing enable coronavirus capture and infection prevention.

Coronaviruses have historically precipitated global pandemics of severe acute respiratory syndrome (SARS) into devastating public health crises. Despite the virus's rapid rate of mutation, all SARS coronavirus 2 (SARS-CoV-2) variants are known to gain entry into host cells primarily through complexation with angiotensin-converting enzyme 2 (ACE2). Although ACE2 has potential as a druggable decoy to block viral entry, its clinical use is complicated by its essential biological role as a carboxypeptidase and hindered by its structural and chemical instability. Here we designed supramolecular filaments, called fACE2, that can silence ACE2's enzymatic activity and immobilize ACE2 to their surface through enzyme-substrate complexation. This docking strategy enables ACE2 to be effectively delivered in inhalable aerosols and improves its structural stability and functional preservation. fACE2 exhibits enhanced and prolonged inhibition of viral entry compared with ACE2 alone while mitigating lung injury in vivo.

Continued Visibility of COVID-19 Article Removals.

OBJECTIVE: The coronavirus disease 2019 pandemic has produced an unprecedented amount of scientific research as well as a high number of article retractions. Social and news media have been used to disseminate scientific research, and this can include retracted or withdrawn research. This risks the persistence of low-quality research and may contribute to controversial ideas or conspiracy theories. METHODS: We examined 34 retracted or withdrawn coronavirus disease 2019 articles using alternative metrics. RESULTS: These articles continued to receive social and news media mentions up to 180 days postremoval, although most mentions occurred within 30 days postremoval. Articles available on preprint servers accounted for 45.5% of total mentions. CONCLUSIONS: A significant, positive correlation was observed among Scimago Journal Rank, Immediacy Index, and Journal Citation Index, and total article mentions.

Alternative publication metrics in the time of COVID-19.

Alternative metrics are unique bibliometrics comprising social, news, and other sources of media outside of traditional academic citations. Some have suggested that these metrics can complement traditional metrics of research impact, including public engagement with research. The COVID-19 pandemic provides a unique opportunity to study alternative metrics and the dissemination of scientific research given the heightened academic and public interest. This study analyzed Altmetric Attention Scores for the top 25 publications on COVID-19 and the top 25 non-COVID-19 publications in 2020. There were significantly higher levels of social attention scores across multiple metrics for COVID-19 articles than for non-COVID-19 articles for that year. There was a slightly higher goodness of fit between Altmetric Attention Scores and academic citations for COVID-19 publications than for non-COVID-19 publications, although trendline differences were not significant. These results suggest that researchers should be aware that their studies can become highly visible on publicly available social and news media platforms, especially during events of high interest (such as a global pandemic).

Academic Journal Retractions and the COVID-19 Pandemic.

The 2020 COVID-19 pandemic has produced an unprecedented amount of scientific research, with over 100,000 articles on the SARS-COV2 virus or the associated pandemic published within the first year. To effectively disseminate such a large volume of research, some academic journal publishers altered their review criteria, and many articles were made available before undergoing a traditional review process. However, with this rapid influx of information, multiple COVID-19 articles have been retracted or withdrawn. Some researchers have expressed concern that these retractions call into question the validity of an expedited review process and the overall quality of the larger body of COVID-19 research. We examined 68 removed articles and determined that many of the articles were removed for unknown reasons (n = 22) or as duplications (n = 12); 24 papers were retracted for more significant reasons (data integrity, plagiarism, reporting or analysis, and IRB or privacy issues). The majority of removed papers were from the USA (n = 23) and China (n = 19).